# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATIONDECISION SUMMARYINSTRUMENT ONLY TEMPLATE

A. 510(k) Number: K071562   
B. Purpose for Submission: Original Traditional 510(k)   
C. Manufacturer and Instrument Name: DREW Scientific, Inc., D3 Hematology analyzer   
D. Type of Test or Tests Performed: 16 Quantitative hematology parameters

# E. System Descriptions:

1. Device Description:

The D3 Hematology analyzer is a stand-alone benchtop, clinical laboratory instrument which analyzes in-vitro samples of whole blood to provice complete blood count and leukocyte 3-part differential count using the impedance and spectrophotometry techniques.

2. Principles of Operation:

The impedance principle of electrical resistance is used for cell counting and sizing of WBCs, RBCs, and Plts. This is combined with optical absorbance of cyanmethemeglobin for hemoglobin. The technology combines to give a full CBC with 3-part differential in just under one minute.

3. Modes of Operation: Open Tube

4. Specimen Identification:

Specimen identification is manual alphanumeric entry. A bar-code reader is an optional accessory.

5. Specimen Sampling and Handling: Manual sample handling using a sampling needle on the front of the instrument.

6. Calibration: Calibration is automatic or manual using DREW EX-CAL manufactured by R&D Systems.

7. Quality Control:

Quality control is performed using DREW EX-TROL control materials (high, normal and low levels), manufactured by R&D Systems. The D3 stores up to 100 results per control batch for 6 different Lots. Results of each lot can be viewed as tables or through Levy-Jennings graphs.

8. Software:

FDA has reviewed applicant’s Hazard Analysis and Software Development processes for this line of product types:

Yes ___X____ or No_ Software documentation was provided at a Moderate Level of Concern.

# F. Regulatory Information:

1. Regulation section: 21 CFR 864.5220, Automated differential cell counter

2. Classification: Class II

3 Product code: GKZ

4. Panel: Hematology (81)

# G. Intended Use:

1. Indication(s) for Use:

The DREW D3 Hematology Analyzer is a fully automated (microprocessor controlled) quantitative hematology analyzer used for the in vitro diagnostic testing of whole blood specimens.

2. Special Conditions for Use Statement(s): N/A

# H. Substantial Equivalence Information:

1. Predicate Device Name(s) and 510(k) numbers: DATACELL 18MS PLUS (K945678)

2. Comparison with Predicate Device:

<table><tr><td colspan="3">Similarities</td></tr><tr><td>Item</td><td>Device</td><td>Predicate</td></tr><tr><td>Instrument</td><td>Hematology Analyzer, CBC + 3 part differential</td><td>Same</td></tr><tr><td>Measurement Principle: WBC, RBC, Plt.</td><td>Impedance</td><td>Same</td></tr><tr><td>Mode:</td><td>Open Tube</td><td>Same</td></tr><tr><td>Parameters: Leukocyte</td><td>WBC, LYM%, LYM#, MID%, MID#, GRA%,</td><td>Same</td></tr><tr><td>Parameters: Erythrocyte</td><td>GRA# RBC#, Hgb, Hct, MCV, MCH, MCHC, RDW</td><td>Same</td></tr><tr><td>Parameters:Thrombocyte</td><td>PLT, MPV</td><td>Same</td></tr><tr><td>Sample Type</td><td>Whole Blood</td><td>Same</td></tr><tr><td>Anti-coagulant</td><td>EDTA K2/ K3</td><td>Identical</td></tr><tr><td>Quality Controls</td><td>Manufactured by: R&amp;D Systems (K843962) for DREW Scientific, EX- TROL</td><td>Same</td></tr><tr><td colspan="1" rowspan="1">Calibrators</td><td colspan="1" rowspan="1">Manufactured by R&amp;DSystems (K003991) forDREW Scientific, EX-CAL</td><td colspan="1" rowspan="1">Same</td></tr></table>

<table><tr><td colspan="3">CAL</td></tr><tr><td colspan="3"></td></tr><tr><td colspan="3">Differences</td></tr><tr><td>Item Measurement Principle:</td><td>Device</td><td>Predicate</td></tr><tr><td>MCV</td><td>Volume integration</td><td>Derived from RBC cell size distribution</td></tr><tr><td>Measurement Principle: HCT</td><td>Volume integration</td><td>Calculation</td></tr><tr><td>RBC Wavelength Specimen Sample</td><td>555nm</td><td>540nm 135.0 μl (whole blood)</td></tr><tr><td>Volume</td><td>10.0 µl (whole blood) 25.0 µl of whole blood diluted into 0.5 ml of</td><td>65.0 µl (whole blood in samples saver mode) 25 μl of whole blood into</td></tr><tr><td rowspan="2">Patient Management Software Operating System</td><td>diluent for prediluted sample mode</td><td>6.0 ml of diluent for prediluted sample mode</td></tr><tr><td>No worklist Uni- directional LIS OS Epsilon embedded</td><td>Worklist, Uni- directional LIS DOS</td></tr><tr><td>Memory Capacity</td><td>firmware Last 1,000 analyses</td><td>100,000 results without histograms, 5000 results</td></tr><tr><td rowspan="5">QC Package</td><td>(demographics, results, &amp; histograms)</td><td>with histograms QC: 8 lots/3 levels (100</td></tr><tr><td>QC: 6 levels (100 results per level)</td><td>results per lot for each of the 3 levels)</td></tr><tr><td>Backup onto USB key 6 controls single level</td><td>8 controls assays (3 levels per lot)</td></tr><tr><td>100 results per control</td><td>100 results per lot (3 levels per lot)</td></tr><tr><td>Levy Jennings plot</td><td>Levy Jennings Plot</td></tr><tr><td></td><td>Assay values can be</td><td>Assay values can be</td></tr><tr><td colspan="3">Differences</td></tr><tr><td>Item</td><td>Device</td><td>Predicate</td></tr><tr><td></td><td>loaded several ways: a) manually, b) via USB key</td><td>loaded several ways: a) manually, b) via modem, c) via diskette</td></tr><tr><td>Display</td><td>Integrated Touch Screen</td><td>LCD Computer Screen</td></tr><tr><td>Computer</td><td>Integrated stand-alone computer</td><td>Built in computer</td></tr><tr><td>Power Requirement</td><td>90 to 265 VAC 50/60Hz</td><td>120 VAC +/- 10% 60Hz</td></tr><tr><td>Maximum Power Consumption</td><td>50W</td><td>300W</td></tr></table>

# I. Special Control/Guidance Document Referenced (if applicable):

Guidance for Industry

# J. Performance Characteristics:

1. Analytical Performance:

a. Accuracy: Table 1

Correlation may be evaluated with respect to DREW DATACELL ${ \mathrm { 1 8 M S + } }$ using human blood samples, for all the measured parameters including 3 part differential.

<table><tr><td rowspan=1 colspan=1>PARAMETERS</td><td rowspan=1 colspan=1>R</td></tr><tr><td rowspan=1 colspan=1>WBC (K/μl)</td><td rowspan=1 colspan=1>&gt; 0.95</td></tr><tr><td rowspan=1 colspan=1>LYM (%)</td><td rowspan=1 colspan=1>&gt;0.95</td></tr><tr><td rowspan=1 colspan=1>MIDS (%)</td><td rowspan=1 colspan=1>&gt;0.90</td></tr><tr><td rowspan=1 colspan=1>GRA (%)</td><td rowspan=1 colspan=1>&gt;0.95</td></tr><tr><td rowspan=1 colspan=1>RBC(M/μL)</td><td rowspan=1 colspan=1>&gt;0.95</td></tr><tr><td rowspan=1 colspan=1>HGB (g/dL)</td><td rowspan=1 colspan=1>&gt;0.95</td></tr><tr><td rowspan=1 colspan=1>HCT (%)</td><td rowspan=1 colspan=1>&gt;0.95</td></tr><tr><td rowspan=1 colspan=1>MCV (fL)</td><td rowspan=1 colspan=1>&gt; 0.95</td></tr><tr><td rowspan=1 colspan=1>PLT (K/μl)</td><td rowspan=1 colspan=1>&gt;0.95</td></tr></table>

Accuracy: Table 2

Correlation was established by Drew Scientific using a DREW DATACELL 18MS and 124 blood samples for all the measured parameters.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=2>Data Range</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>PARAMETERS</td><td rowspan=1 colspan=1>Minimum</td><td rowspan=1 colspan=1>Maximum</td><td rowspan=1 colspan=1>R</td></tr><tr><td rowspan=1 colspan=1>WBC (K/μl)</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>26.2</td><td rowspan=1 colspan=1>0.998</td></tr><tr><td rowspan=1 colspan=1>LYM (%)</td><td rowspan=1 colspan=1>2.3</td><td rowspan=1 colspan=1>63.1</td><td rowspan=1 colspan=1>0.989</td></tr><tr><td rowspan=1 colspan=1>MIDS (%)</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>22.2</td><td rowspan=1 colspan=1>0.956</td></tr><tr><td rowspan=1 colspan=1>GRA (%)</td><td rowspan=1 colspan=1>24.9</td><td rowspan=1 colspan=1>94.8</td><td rowspan=1 colspan=1>0.988</td></tr><tr><td rowspan=1 colspan=1>RBC(M/μL)</td><td rowspan=1 colspan=1>1.01</td><td rowspan=1 colspan=1>7.13</td><td rowspan=1 colspan=1>0.997</td></tr><tr><td rowspan=1 colspan=1>HGB (g/dL)</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>20.1</td><td rowspan=1 colspan=1>0.997</td></tr><tr><td rowspan=1 colspan=1>HCT (%)</td><td rowspan=1 colspan=1>8.7</td><td rowspan=1 colspan=1>62.7</td><td rowspan=1 colspan=1>0.992</td></tr><tr><td rowspan=1 colspan=1>MCV (fL)</td><td rowspan=1 colspan=1>61.0</td><td rowspan=1 colspan=1>115.0</td><td rowspan=1 colspan=1>0.979</td></tr><tr><td rowspan=1 colspan=1>RDW (%)</td><td rowspan=1 colspan=1>11.2</td><td rowspan=1 colspan=1>30.5</td><td rowspan=1 colspan=1>0.830</td></tr><tr><td rowspan=1 colspan=1>PLT (K/μl)</td><td rowspan=1 colspan=1>57</td><td rowspan=1 colspan=1>917</td><td rowspan=1 colspan=1>0.974</td></tr><tr><td rowspan=1 colspan=1>MPV (fL)</td><td rowspan=1 colspan=1>6.5</td><td rowspan=1 colspan=1>13.5</td><td rowspan=1 colspan=1>0.804</td></tr></table>

Accuracy: Table 3

An independent external laboratory obtained the following results based on 77 samples.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=2>Data Range</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>PARAMETERS</td><td rowspan=1 colspan=1>Minimum</td><td rowspan=1 colspan=1>Maximum</td><td rowspan=1 colspan=1>R</td></tr><tr><td rowspan=1 colspan=1>WBC (K/μl)</td><td rowspan=1 colspan=1>4.3</td><td rowspan=1 colspan=1>16.8</td><td rowspan=1 colspan=1>0.996</td></tr><tr><td rowspan=1 colspan=1>LYM (%)</td><td rowspan=1 colspan=1>7.8</td><td rowspan=1 colspan=1>48.1</td><td rowspan=1 colspan=1>0.973</td></tr><tr><td rowspan=1 colspan=1>MIDS (%)</td><td rowspan=1 colspan=1>3.2</td><td rowspan=1 colspan=1>8.8</td><td rowspan=1 colspan=1>0.937</td></tr><tr><td rowspan=1 colspan=1>GRA (%)</td><td rowspan=1 colspan=1>44.9</td><td rowspan=1 colspan=1>88.5</td><td rowspan=1 colspan=1>0.974</td></tr><tr><td rowspan=1 colspan=1>RBC (M/μL)</td><td rowspan=1 colspan=1>2.76</td><td rowspan=1 colspan=1>6.24</td><td rowspan=1 colspan=1>0.983</td></tr><tr><td rowspan=1 colspan=1>HGB (g/dL)</td><td rowspan=1 colspan=1>9.0</td><td rowspan=1 colspan=1>16.2</td><td rowspan=1 colspan=1>0.990</td></tr><tr><td rowspan=1 colspan=1>HCT (%)</td><td rowspan=1 colspan=1>27.8</td><td rowspan=1 colspan=1>50.3</td><td rowspan=1 colspan=1>0.968</td></tr><tr><td rowspan=1 colspan=1>MCV (fL)</td><td rowspan=1 colspan=1>70.0</td><td rowspan=1 colspan=1>101.0</td><td rowspan=1 colspan=1>0.962</td></tr></table>

<table><tr><td rowspan=1 colspan=1>RDW (%)</td><td rowspan=1 colspan=1>11.0</td><td rowspan=1 colspan=1>15.7</td><td rowspan=1 colspan=1>0.757</td></tr><tr><td rowspan=1 colspan=1>PLT (K/μl)</td><td rowspan=1 colspan=1>91</td><td rowspan=1 colspan=1>439</td><td rowspan=1 colspan=1>0.977</td></tr><tr><td rowspan=1 colspan=1>MPV (fL)</td><td rowspan=1 colspan=1>6.3</td><td rowspan=1 colspan=1>13.0</td><td rowspan=1 colspan=1>0.923</td></tr></table>

# b. Precision/Reproducibility: Table 4

Repeatability or simple precision was evaluated by Drew Scientific using a normal whole blood for 20 replicates. Repeatability is expressed as coefficient of variation (CV).

Precision: Table 5   

<table><tr><td rowspan=1 colspan=1>Parameters</td><td rowspan=1 colspan=1>Level</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>CV%</td></tr><tr><td rowspan=1 colspan=1>WBC</td><td rowspan=1 colspan=1>≥ to 6.0 × (K/μL)</td><td rowspan=1 colspan=1>7.98</td><td rowspan=1 colspan=1>2.0</td></tr><tr><td rowspan=1 colspan=1>LYM%</td><td rowspan=1 colspan=1>≥ to 15 %</td><td rowspan=1 colspan=1>32.23</td><td rowspan=1 colspan=1>2.9</td></tr><tr><td rowspan=1 colspan=1>MID%</td><td rowspan=1 colspan=1>≥ to 5 %</td><td rowspan=1 colspan=1>7.94</td><td rowspan=1 colspan=1>3.5</td></tr><tr><td rowspan=1 colspan=1>GRA%</td><td rowspan=1 colspan=1>≥ to 50 %</td><td rowspan=1 colspan=1>59.83</td><td rowspan=1 colspan=1>1.5</td></tr><tr><td rowspan=1 colspan=1>RBC</td><td rowspan=1 colspan=1>≥ to 4.0 × (M/μL)</td><td rowspan=1 colspan=1>5.168</td><td rowspan=1 colspan=1>1.0</td></tr><tr><td rowspan=1 colspan=1>HGB</td><td rowspan=1 colspan=1>≥ to 12.0 g/dL</td><td rowspan=1 colspan=1>15.46</td><td rowspan=1 colspan=1>0.6</td></tr><tr><td rowspan=1 colspan=1>HCT</td><td rowspan=1 colspan=1>≥ to 35.0 %</td><td rowspan=1 colspan=1>42.93</td><td rowspan=1 colspan=1>1.0</td></tr><tr><td rowspan=1 colspan=1>MCV</td><td rowspan=1 colspan=1>≥ to 80 fL</td><td rowspan=1 colspan=1>83.07</td><td rowspan=1 colspan=1>0.4</td></tr><tr><td rowspan=1 colspan=1>RDW</td><td rowspan=1 colspan=1>≥ to 12 %</td><td rowspan=1 colspan=1>13.24</td><td rowspan=1 colspan=1>3.3</td></tr><tr><td rowspan=1 colspan=1>PLT</td><td rowspan=1 colspan=1>≥ to 200× (K/μL)</td><td rowspan=1 colspan=1>307.2</td><td rowspan=1 colspan=1>3.6</td></tr><tr><td rowspan=1 colspan=1>MPV</td><td rowspan=1 colspan=1>≥ to 7 fL</td><td rowspan=1 colspan=1>7.72</td><td rowspan=1 colspan=1>1.2</td></tr></table>

Two independent external laboratories using D3 analyzer obtained the following results using normal controls

<table><tr><td rowspan=8 colspan=1></td><td rowspan=1 colspan=7>Laboratory A (10 replicates - normal control)</td></tr><tr><td rowspan=1 colspan=2>Parameters</td><td rowspan=1 colspan=2>Level</td><td rowspan=1 colspan=2>Mean</td><td rowspan=1 colspan=1>CV%</td></tr><tr><td rowspan=1 colspan=2>WBC</td><td rowspan=1 colspan=2>≥ to 6.0 × (K/μL)</td><td rowspan=1 colspan=2>7.59</td><td rowspan=1 colspan=1>1.4</td></tr><tr><td rowspan=1 colspan=2>LYM%</td><td rowspan=1 colspan=2>≥ to 15 %</td><td rowspan=1 colspan=2>25.88</td><td rowspan=1 colspan=1>1.6</td></tr><tr><td rowspan=1 colspan=2>MID%</td><td rowspan=1 colspan=2>≥ to 5 %</td><td rowspan=1 colspan=2>6.61</td><td rowspan=1 colspan=1>3.1</td></tr><tr><td rowspan=1 colspan=2>GRA%</td><td rowspan=1 colspan=2>≥ to 50 %</td><td rowspan=1 colspan=2>67.51</td><td rowspan=1 colspan=1>0.5</td></tr><tr><td rowspan=1 colspan=2>RBC</td><td rowspan=1 colspan=2>≥ to 4.0 × (M/μL)</td><td rowspan=1 colspan=2>4.573</td><td rowspan=1 colspan=1>1.0</td></tr><tr><td rowspan=1 colspan=2>HGB</td><td rowspan=1 colspan=2>≥ to 12.0 g/dL</td><td rowspan=1 colspan=2>13.63</td><td rowspan=1 colspan=1>1.0</td></tr><tr><td rowspan=1 colspan=2>HCT</td><td rowspan=1 colspan=2>≥ to 35.0 %</td><td rowspan=1 colspan=2>39.90</td><td rowspan=1 colspan=2>1.0</td></tr><tr><td rowspan=1 colspan=2>MCV</td><td rowspan=1 colspan=2>≥ to 80 fL</td><td rowspan=1 colspan=2>87.26</td><td rowspan=1 colspan=2>0.3</td></tr><tr><td rowspan=1 colspan=2>RDW</td><td rowspan=1 colspan=2>≥ to 12 %</td><td rowspan=1 colspan=2>14.88</td><td rowspan=1 colspan=2>2.2</td></tr><tr><td rowspan=1 colspan=2>PLT</td><td rowspan=1 colspan=2>≥ to 200× (K/μL)</td><td rowspan=1 colspan=2>221.6</td><td rowspan=1 colspan=2>2.7</td></tr><tr><td rowspan=1 colspan=2>MPV</td><td rowspan=1 colspan=2>≥ to 7 fL</td><td rowspan=1 colspan=2>7.36</td><td rowspan=1 colspan=2>2.9</td></tr></table>

Split fresh human samples were analyzed on duplicate at two independent external laboratories within the same time frame. Inter-laboratory precision was calculated us ISO 5725-2 procedure.

<table><tr><td rowspan=1 colspan=2>Parameter</td><td rowspan=1 colspan=1>WBC</td><td rowspan=1 colspan=1>LYM %</td><td rowspan=1 colspan=1>MID%</td><td rowspan=1 colspan=1>GRA%</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>6.90</td><td rowspan=1 colspan=1>26.03</td><td rowspan=1 colspan=1>6.35</td><td rowspan=1 colspan=1>67.5</td></tr><tr><td rowspan=1 colspan=1>Est. of repeatability variance</td><td rowspan=1 colspan=1>$S.2}$</td><td rowspan=1 colspan=1>0.0100</td><td rowspan=1 colspan=1>0.5625</td><td rowspan=1 colspan=1>0.0250</td><td rowspan=1 colspan=1>0.392</td></tr><tr><td rowspan=1 colspan=1>Est. between laboratory variance</td><td rowspan=1 colspan=1>$S ^2}$</td><td rowspan=1 colspan=1>0.0000</td><td rowspan=1 colspan=1>0.5000</td><td rowspan=1 colspan=1>0.0675</td><td rowspan=1 colspan=1>1.705</td></tr><tr><td rowspan=4 colspan=1>Estimate reproducibility variance</td><td rowspan=1 colspan=1>$S\^r{2}$</td><td rowspan=1 colspan=1>0.0100</td><td rowspan=1 colspan=1>1.0625</td><td rowspan=1 colspan=1>0.0925</td><td rowspan=1 colspan=1>2.097</td></tr><tr><td rowspan=1 colspan=1>S</td><td rowspan=1 colspan=1>0.1000</td><td rowspan=1 colspan=1>0.7500</td><td rowspan=1 colspan=1>0.1581</td><td rowspan=1 colspan=1>0.626</td></tr><tr><td rowspan=1 colspan=1>SR</td><td rowspan=1 colspan=1>0.1000</td><td rowspan=1 colspan=1>1.0308</td><td rowspan=1 colspan=1>0.3041</td><td rowspan=1 colspan=1>1.448</td></tr><tr><td rowspan=1 colspan=1>CV%</td><td rowspan=1 colspan=1>1.45%</td><td rowspan=1 colspan=1>3.96%</td><td rowspan=1 colspan=1>4.79%</td><td rowspan=1 colspan=1>2.14</td></tr><tr><td rowspan=1 colspan=2>CV% claim</td><td rowspan=1 colspan=1>&lt;2.5%</td><td rowspan=1 colspan=1>&lt;5%</td><td rowspan=1 colspan=1>&lt; 10%</td><td rowspan=1 colspan=1>&lt; 3%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Parameter</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>RBC</td><td rowspan=1 colspan=1>Hgb</td><td rowspan=1 colspan=1>HCT</td><td rowspan=1 colspan=1>MCV</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>4.565</td><td rowspan=1 colspan=1>14.00</td><td rowspan=1 colspan=1>41.48</td><td rowspan=1 colspan=1>90.9</td></tr><tr><td rowspan=1 colspan=1>Est. of repeatability variance</td><td rowspan=1 colspan=1>$S.2}$</td><td rowspan=1 colspan=1>0.0062</td><td rowspan=1 colspan=1>0.0050</td><td rowspan=1 colspan=1>0.4625</td><td rowspan=1 colspan=1>0.012</td></tr><tr><td rowspan=1 colspan=1>Est. between laboratory variance</td><td rowspan=1 colspan=1>$S {2}$</td><td rowspan=1 colspan=1>0.0001</td><td rowspan=1 colspan=1>0.0025</td><td rowspan=1 colspan=1>0.0000</td><td rowspan=1 colspan=1>0.775</td></tr><tr><td rowspan=4 colspan=1>Estimate reproducibility variance</td><td rowspan=1 colspan=1>$S\^{2}$</td><td rowspan=1 colspan=1>0.0063</td><td rowspan=1 colspan=1>0.0075</td><td rowspan=1 colspan=1>0.4625</td><td rowspan=1 colspan=1>0.787</td></tr><tr><td rowspan=1 colspan=1>S</td><td rowspan=1 colspan=1>0.0791</td><td rowspan=1 colspan=1>0.0707</td><td rowspan=1 colspan=1>0.6801</td><td rowspan=1 colspan=1>0.111</td></tr><tr><td rowspan=1 colspan=1>SR</td><td rowspan=1 colspan=1>0.0795</td><td rowspan=1 colspan=1>0.0866</td><td rowspan=1 colspan=1>0.6801</td><td rowspan=1 colspan=1>0.887</td></tr><tr><td rowspan=1 colspan=1>CV%</td><td rowspan=1 colspan=1>1.74%</td><td rowspan=1 colspan=1>0.62%</td><td rowspan=1 colspan=1>1.64%</td><td rowspan=1 colspan=1>0.98</td></tr><tr><td rowspan=1 colspan=2>CV% claim</td><td rowspan=1 colspan=1>&lt;2%</td><td rowspan=1 colspan=1>&lt;1.5%</td><td rowspan=1 colspan=1>&lt;2%</td><td rowspan=1 colspan=1>&lt; 1%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Parameter</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>PLT</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>287.8</td></tr><tr><td rowspan=1 colspan=1>Est. of repeatability variance</td><td rowspan=1 colspan=1>$S$2}$</td><td rowspan=1 colspan=1>151.25</td></tr><tr><td rowspan=1 colspan=1>Est. between laboratory variance</td><td rowspan=1 colspan=1>$S^2}$</td><td rowspan=1 colspan=1>0.00</td></tr><tr><td rowspan=4 colspan=1>Estimate reproducibility variance</td><td rowspan=1 colspan=1>$S^2}$</td><td rowspan=1 colspan=1>151.25</td></tr><tr><td rowspan=1 colspan=1>Sr</td><td rowspan=1 colspan=1>12.30</td></tr><tr><td rowspan=1 colspan=1>SR</td><td rowspan=1 colspan=1>12.30</td></tr><tr><td rowspan=1 colspan=1>CV%</td><td rowspan=1 colspan=1>4.27%</td></tr><tr><td rowspan=1 colspan=2>CV% claim</td><td rowspan=1 colspan=1>&lt; 5%</td></tr></table>

Linearity was established by Drew Scientific using a commercial linearity kit, each level was measured five times. In the case of MCV, latex spheres were used.

<table><tr><td rowspan=1 colspan=1>Parameters(Units)</td><td rowspan=1 colspan=1>Overall measuredrange</td></tr><tr><td rowspan=1 colspan=1>WBC (K/μL)</td><td rowspan=1 colspan=1>0.6- 117.6</td></tr><tr><td rowspan=1 colspan=1>RBC(M/μL)</td><td rowspan=1 colspan=1>0.257.98</td></tr><tr><td rowspan=1 colspan=1>HGB (g/dL)</td><td rowspan=1 colspan=1>0.6-23.12</td></tr><tr><td rowspan=1 colspan=1>HCT (%)</td><td rowspan=1 colspan=1>2.2-71.0</td></tr><tr><td rowspan=1 colspan=1>MCV (fL)</td><td rowspan=1 colspan=1>43 - 231</td></tr><tr><td rowspan=1 colspan=1>PLT (K/μL)</td><td rowspan=1 colspan=1>7- 2,806</td></tr></table>

# d. Carryover: Table 8

Carryover was evaluated by Drew Scientific by analyzing three human samples with a high concentration, followed by (3) x runs from low (human) concentration samples. The test was repeated three times and the highest value is reported below.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>WBC</td><td rowspan=1 colspan=1>RBC</td><td rowspan=1 colspan=1>HGB</td><td rowspan=1 colspan=1>PLT</td></tr><tr><td rowspan=1 colspan=1>High concentration value</td><td rowspan=1 colspan=1>22.7</td><td rowspan=1 colspan=1>5.93</td><td rowspan=1 colspan=1>19.4</td><td rowspan=1 colspan=1>638</td></tr><tr><td rowspan=1 colspan=1>Low concentration value</td><td rowspan=1 colspan=1>3.2</td><td rowspan=1 colspan=1>2.13</td><td rowspan=1 colspan=1>6.8</td><td rowspan=1 colspan=1>85</td></tr><tr><td rowspan=1 colspan=1>Measured carry-over (%)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1.34%</td><td rowspan=1 colspan=1>0.80%</td><td rowspan=1 colspan=1>1.50%</td></tr><tr><td rowspan=1 colspan=1>Maximum carry-over (%)</td><td rowspan=1 colspan=1>&lt;2.0</td><td rowspan=1 colspan=1>&lt;2.0</td><td rowspan=1 colspan=1>&lt;2.0</td><td rowspan=1 colspan=1>&lt;2.0</td></tr></table>

The percentage of carry-over between samples is calculated with the following formula:

Table 5-14. Possible Interferences of Samples   

<table><tr><td rowspan=1 colspan=1>Parameter</td><td rowspan=1 colspan=1>Specimen</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Typical Findings</td></tr><tr><td rowspan=1 colspan=1>WBC</td><td rowspan=1 colspan=1>Nucleated RBCCryo-globulinsPlatelet aggregation</td><td rowspan=1 colspan=1>(+)(+)</td><td rowspan=1 colspan=1>NRBC on smearPlatelet aggregates on smear</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td></td></tr><tr><td rowspan=1 colspan=1>RBC</td><td rowspan=1 colspan=1>Cold AgglutininSevere MicrocytosisFragmented RBCLeukocytes (&gt;100.000/μL)</td><td rowspan=1 colspan=1>(-)(-)(-)(+)</td><td rowspan=1 colspan=1>↑MCV (increase), ↓HCT (decrease), red cellclumping on smear.Elevation of WBC count</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td></td></tr><tr><td rowspan=1 colspan=1>HGB</td><td rowspan=1 colspan=1>Leukocytes (&gt;100,000/μL)LipemiaAbnormal Protein</td><td rowspan=1 colspan=1>()</td><td rowspan=1 colspan=1>Elevation of Hgb↑MCHC (increase), &quot;milky&quot; appearance of plasma↑MCHC (increase), Lyses Hgb/WBC sample turncloudy.</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td></td></tr><tr><td rowspan=1 colspan=1>HCT</td><td rowspan=1 colspan=1>Cold AgglutininLeukocytes (&gt;100,000/μL)Abnormal Red Cell Fragility</td><td rowspan=1 colspan=1>(-)(3)</td><td rowspan=1 colspan=1>↑MCV (increase), ↓HCT (decrease), red cellclumping on smear.Elevation of WBC, ↑HCT</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td></td></tr><tr><td rowspan=1 colspan=1>PLT</td><td rowspan=1 colspan=1>PseudothrombocytopeniaPlatelet AggregationIncreased Microcytosis</td><td rowspan=1 colspan=1>(-)(-)(+)(-)</td><td rowspan=1 colspan=1>Platelet Satellitism on smearPlatelet Aggregates on smear↓MCV (decrease),</td></tr></table>

$( + )$ : Instrument count is affected by an increased result.

2. Other Supportive Instrument Performance Data Not Covered Above:

N/A

# K. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# L. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.